Molecular Events in Lung Cancer and Implications for Prevention and Therapy
Part of the M.D. Anderson Cancer Care Series book series (MDCCS)
KeywordsLung Cancer Small Cell Lung Cancer Lung Tumor Lung Cancer Risk Small Cell Lung Carcinoma
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Unable to display preview. Download preview PDF.
- Hittelman WN. Genetic instability assessments in the lung cancerization field. In: Brambilla C, Brambilla E, eds. Lung Tumors: Fundamental Biology and Clinical Management. New York, NY: Marcel Dekker; 1999:255–267.Google Scholar
- Hittelman WN. Molecular cytogenetic evidence for multistep tumorigenesis: implications for risk assessment and early detection. In: Srivastava S, Hensen DE, Gazdar A, eds. Molecular Pathology of Early Cancer. Washington, DC: IOS Press; 1999:385–404.Google Scholar
- Kurie JM, Lippman SM, Hong WK. Chemoprevention trials: epithelial carcinogenesis and the biological basis of intervention. In: Bertino JR, ed. Encyclopedia of Cancer. Vol 1. San Diego, Calif: Academic Press; 1996;341–354.Google Scholar
- Saccomano G, Archer VE, Auerbach O, et al. Development of carcinoma of the lung as reflected in exfoliated cells. Cancer 1974;33:256–270.Google Scholar
- Swisher SG, Roth JA, Komaki R, et al. A phase II trial of adenoviral mediated p53 gene transfer (RPR/INGN 201) in conjunction with radiation therapy in patients with localized non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 2000;19:461.Google Scholar
© Springer-Verlag New York, Inc. 2003